SCHEMBL9718382

SCHEMBL9718382

Cc1ccc(C(=O)S(=O)(=O)NCCc2ccc(C(=O)CCC(=O)O)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.57
L3MBTL1 Q9Y468 1/20 0.52
AKR1C3 P42330 1/20 0.46
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 2/20 0.46
MAPT P10636 2/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
TBXA2R P21731 1/20 0.43
TBXAS1 P24557 1/20 0.43
ATM Q13315 1/20 0.42
FFAR1 O14842 2/20 0.42
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9660574 0.85 ALDH1A1 (0.68) KMT2AAKR1C3ALDH1A1MEN1MAPT
SCHEMBL11575084 0.81 TBXA2R (0.58) KMT2AAKR1C3ALDH1A1MEN1MAPT
SCHEMBL16922187 0.76 KMT2A (1.00) KMT2AL3MBTL1ALDH1A1MEN1LMNA
SCHEMBL822930 0.76 KMT2A (1.00) KMT2AL3MBTL1ALDH1A1MEN1LMNA
Succinic Acid SCHEMBL8467793 0.76 KMT2A (1.00) KMT2AL3MBTL1ALDH1A1MEN1LMNA
SCHEMBL10867378 0.75 ALDH1A1 (0.56) L3MBTL1ALDH1A1MAPTLMNANPC1
SCHEMBL9659259 0.75 ALDH1A1 (0.71) L3MBTL1AKR1C3ALDH1A1MAPTTBXA2R
SCHEMBL10865713 0.74 L3MBTL1 (0.66) KMT2AL3MBTL1ALDH1A1MAPTLMNA
SCHEMBL10463031 0.73 ALDH1A1 (0.64) KMT2AL3MBTL1ALDH1A1MEN1MAPT
SCHEMBL9130450 0.73 TBXA2R (0.53) KMT2AL3MBTL1AKR1C3ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0260527-B1 SYNERGETIC COMBINATION COMPRISING A PHOSPHODIESTERASE INHIBITOR AND A THROMBOXAN-A2-ANTAGONIST, AND THEIR USE OR MANUFACTURE Dr. Karl Thomae GmbH (DE) 1992-04-01 EP disclosed
EP-0260527-A2 Synergetic combination comprising a phosphodiesterase inhibitor and a thromboxan-A2-antagonist, and their use or manufacture Dr. Karl Thomae GmbH (DE) 1988-03-23 EP disclosed
EP-0194548-A2 Sulfonylaminoethyl compounds, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1986-09-17 EP disclosed